A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma.

Mudigonda TV, Wyman K, Spigel DR, Dahlman KB, Greco FA, Puzanov I, Kelley MC, Hainsworth JD, Sosman JA, Johnson DB
Pigment Cell Melanoma Res. 2016 29 (1): 101-3

PMID: 26176864 · DOI:10.1111/pcmr.12394

MeSH Terms (8)

Antineoplastic Combined Chemotherapy Protocols Bevacizumab Disease-Free Survival Erlotinib Hydrochloride Humans Melanoma Neoplasm Metastasis Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links